Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rabinowitz

Showing results (441-450 of 480) with videos related to

Pageof 48
Sort By:
Nature Metabolism|June 23, 2026
Host metabolism can produce many indoles and phenols independently of the microbiomeJenna E AbuSalim, Kellen Olszewski, Salma Youssef, et al.
Nature|June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature Medicine|December 27, 2016
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumorsShawn M Davidson, Oliver Jonas, Mark A Keibler, et al.
Nature Cardiovascular Research|September 18, 2024
Cardiac NAD<sup>+</sup> depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergeticsKhanh V Doan, Timothy S Luongo, Thato T Ts'olo, et al.
Molecular Cancer Therapeutics|January 5, 2023
Correction: Novel Pyrrolo[3,2-d]Pyrimidine Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 6, 2013
Adhesion molecules, endothelin-1 and lung function in seven population-based cohortsE C Oelsner, T D Pottinger, K M Burkart, et al.
Cell|December 10, 2020
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityAlison E Ringel, Jefte M Drijvers, Gregory J Baker, et al.
Cancer|March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancerGayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Molecular Cancer Therapeutics|July 11, 2019
Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Pageof 48

Showing results (441-450 of 480) with videos related to

Sort By:
Pageof 48
Nature Metabolism|June 23, 2026
Host metabolism can produce many indoles and phenols independently of the microbiomeJenna E AbuSalim, Kellen Olszewski, Salma Youssef, et al.
Nature|June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature Medicine|December 27, 2016
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumorsShawn M Davidson, Oliver Jonas, Mark A Keibler, et al.
Nature Cardiovascular Research|September 18, 2024
Cardiac NAD<sup>+</sup> depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergeticsKhanh V Doan, Timothy S Luongo, Thato T Ts'olo, et al.
Molecular Cancer Therapeutics|January 5, 2023
Correction: Novel Pyrrolo[3,2-d]Pyrimidine Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 6, 2013
Adhesion molecules, endothelin-1 and lung function in seven population-based cohortsE C Oelsner, T D Pottinger, K M Burkart, et al.
Cell|December 10, 2020
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityAlison E Ringel, Jefte M Drijvers, Gregory J Baker, et al.
Cancer|March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancerGayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Molecular Cancer Therapeutics|July 11, 2019
Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Pageof 48